Alpesh Amin, MD (hospitalist)plus
Alpesh Amin, MD, MBA, MACP, SFHM is an internationally recognized leader in the field of hospital medicine and Chairman of the University of California, Irvine Health Department of Medicine, professor at the School of Medicine, and Executive Director of the Hospitalist Program School of Medicine.
Dr. Amin has lead efforts to improve the quality of care and safety of patients in hospital environments. He has also served as principal investigator, co-investigator, and faculty sponsor on clinical trials, registries and research projects focusing on clinical topics such as VTE, pneumonia, diabetes, and heart failure.
Dr. Amin has authored or co-authored more than 100 peer-reviewed articles. He is the co-editor/co-author of the Core Competencies in Hospital Medicine, published by the Society of Hospital Medicine (SHM) and co-editor of Contemporary Hospitalists’ Guide to Anticoagulation.
He is the recipient of numerous federally funded, industry-sponsored, and foundation awards focused on quality of care, medical education, and outcomes research. Honors have included the American College of Physicians Special Recognition Award; “America’s Top Physicians” by the Consumers’ Research Council of America; the Orange County Physician of Excellence Award; ACP’s Top 10 Hospitalist Award; and the Venous Research Award for Quality Improvement and Implementation of Best Practices from the Venous Disease Coalition (VDC)/Vascular Disease Foundation (VDF).
He is a senior fellow of the Society of Hospital Medicine (SHM), master of the American College of Physicians (ACP), and a member of the Society of General Internal Medicine and Academic Chiefs and Leaders of General Internal Medicine.
Dr. Amin is a graduate of Northwestern University Medical School in Chicago. He completed his internship, residency in internal medicine, and chief residency at UCI. He also earned a healthcare MBA at UCI and an undergraduate degree in biomedical engineering from the University of California, San Diego.
Kathleen Fraser, RN-BC, MSN, MHA, CCM (case manager)plus
Kathleen Fraser, RN-BC, MSN, MHA, CCM, CRRN, is President of the Case Management Society of America (CMSA). She has also been a Regional Team Manager of Managed Care for Zurich Insurance for over 12 years.
Kathleen has an extensive background and 32 years of experience in Hospital Nursing, which includes Emergency Room, Labor and Delivery and as a Director of Nursing.
Kathleen has served on CMSA's National Board of Directors for the past four years. She is on the Role Delineation and Expert Panel Committees of the American Nurses Association Certification Council for Case Management.
Len Fromer, MD (primary care)plus
Leonard M. Fromer, MD is the Executive Medical Director of the Group Practice Forum and an assistant clinical professor in the Department of Family Medicine at the University of California at Los Angeles.
Dr. Fromer is a Fellow of the American Academy of Family Physicians, and a diplomat of both the American Board for Family Practice and the National Board of Medical Examiners. Dr. Fromer is a past president of the California Academy of Family Physicians and has served as a member and Chairman of the American Academy of Family Physicians Commission on Health Care services for more than ten years.
Dr. Fromer received his medical degree at SUNY Downstate Medical Center in Brooklyn and completed his residency at the University of California Irvine/Long Beach Memorial Hospital.
He also lectures extensively on the topics of health-system reform, the patient-centered medical home and the accountable care organization. He has been featured on CBS News, ABC News, and in the New York Times.
Casey S. Jones, PhD, RN, ANP-C (nurse practitioner)plus
Casey Jones is a certified adult nurse practitioner, registered nurse and PhD, currently practicing at the Texas Pulmonary & Critical Care Consultants. Additionally, she is acting as an adjunct professor at Texas Woman’s University. Jones received her medical degree at the University of Texas at Arlington.
Tom Kallstrom, RRT (respiratory therapist)plus
Thomas J. Kallstrom, MBA, RRT, FAARC, is the Executive Director and CEO of the American Association for Respiratory Care.
Kallstrom has been a respiratory therapist for more 30 years, six of which were spent as the AARC’s Chief Operating Officer. Prior to that, he held staff and management positions with Rainbow Babies and Children’s Hospital in Cleveland, OH and later at the Cleveland Clinic system. He began his career in Minnesota at University of Minnesota Hospitals.
He was a member of the Board of Directors for the AARC before joining the organization full-time. He has been recognized as a leader in asthma disease management, working with government agencies such as the Environmental Protection Agency (EPA) and National Heart Lung and Blood Institute (NHLBI) and the National Asthma Education and Prevention Program, leading the development of asthma and COPD education for clinicians and patients, and representing the respiratory therapist’s interests with industry.
Jerry Krishnan, MD (pulmonologist)plus
Dr. Jerry Krishnan is Professor of Medicine and Public Health, and Associate Vice President for Population Health Sciences in the Office of Health Affairs at the University of Illinois Hospital & Health Sciences System (UI Health System). He is a recognized expert in the care of patients with asthma, chronic obstructive pulmonary disease (COPD) and other complex obstructive lung disorders. His clinical work focuses on identifying new treatment strategies for patients with asthma and COPD. Dr. Krishnan also served as a member of the Pulmonary-Allergy Drugs Advisory Committee for the U.S. Food and Drug Administration (FDA) from 2007-2012.
He is a member of the National Committee for Quality Assurance (NCQA) Respiratory Measurement Advisory Panel and the National Heart, Lung, and Blood Institute's Clinical Trials Review Committee.
He received his medical degree from Baylor College of Medicine in Houston and completed his residency in Internal Medicine and his fellowship in Pulmonary/Critical Care Medicine at the Johns Hopkins Hospital. He received a PhD in Clinical Investigation from the Johns Hopkins Bloomberg School of Public Health.
Dr. Krishnan is a leader in the field of comparative effectiveness research and an expert in clinical investigation for asthma and chronic obstructive pulmonary disease (COPD). Dr. Krishnan leads several Patient Centered Outcomes Research Institute (PCORI)-funded multi-investigator groups, including: examining the effectiveness of interventions to improve outcomes after hospital discharge (PArTNER); the use of supplemental oxygen (PELICAN); and the care of children with presenting to the emergency department with uncontrolled asthma (the CHICAGO Trial). He is also an investigator in PCORnet (the National Patient-Centered Clinical Research Network), including CAPriCORN and the COPD Patient-Powered Research Network.
Rhonda Rhotert, MPAS, PA-C (physician assistant)plus
Rhonda Rotert, MPAS, PA-C is the Director of PA/NP services at McFarland Clinic in Ames, Iowa and specializes in pulmonology. Rotert is certified by the National Commission on Certification of Physician Assistants and is affiliated with Mary Greeley Medical Center in Ames.
Rotert is a Fellow of the American Academy of Physician Assistants and a member of the Iowa Physician Assistant Society.
Jean Rommes, PhD (patient)plus
Dr. Jean Rommes, PhD, is a COPD patient and advocate with intimate knowledge and experience with the challenges for the care and treatment of patients.
Dr. Rommes has participated in various projects related to the care and management of patients diagnosed with COPD with a key focus on issues and problems of patients. Dr. Rommes has contributed significantly to the advancement of the care and treatment of patients diagnosed with COPD throughout the continuum of care; most importantly with a patient's perspective. Dr. Rommes is a member of the Pulmonary Horizons program committee and is a featured keynote speaker at Pulmonary Horizons conferences. She is also a board member of the Patient-Powered Research Network. She has been featured in New York Times article about COPD.
Dr. Rommes attended Michigan State University and Syracuse University. She is a Doctor of Philosophy in Higher Education Administration; she has a MS in Student Personnel Administration, and BA in English.
Byron Thomashow, MD (pulmonologist)plus
Dr. Byron Thomashow is a Professor of Medicine Columbia University Medical Center and an attending physician at the New York-Presbyterian Hospital. He also serves as the chairman of the COPD Foundation Board of Directors. He serves as medical co-director of the Jo-Ann LeBuhn Center for Chest Disease on the Columbia campus and is medical director of the New York-Presbyterian Lung Volume Reduction program.
Dr. Thomashow received his medical degree from Columbia University College of Physicians & Surgeons and completed his residency from St. Luke’s-Roosevelt Hospital Center. He completed his fellowship at the Harlem Hospital Center in New York City.
In 2013, Dr. Thomashow served as the co-primary investigator at the Columbia site for the National Emphysema Treatment Trial and remains actively involved in multiple national clinical research projects. His research focuses on COPD, lung volume reduction, exercise physiology and optical electronic plethymography. Most recently, Thomashow investigated ventilatory efficiency before and after lung volume reduction surgery. He was awarded the 2013 ATS Public Advisory Roundtable Excellence Award.
John W. Walsh (patient)plus
John W. Walsh is the Co-founder and President of the COPD Foundation, and a COPD patient and advocate. He was diagnosed with Alpha-1 Antitrypsin Deficiency (AATD) in 1989, and upon learning there was no organized effort to promote research and find a cure for the disease, decided to take action.
In 1995, he co-founded AlphaNet, a not-for profit disease management service company, providing comprehensive care exclusively for individuals with AATD. Today, Walsh serves as President of AlphaNet, which provides healthcare services to 3,000 individuals with AATD in all 50 states, Puerto Rico and the Virgin Islands.
Walsh also co-founded the Alpha-1 Foundation, a not-for-profit corporation dedicated to providing the leadership and resources to increase research, improve health, promote worldwide detection, and find a cure for AATD.
Walsh serves as an active member of various voluntary health agency committees and governmental advisory committees. He was appointed to serve on the NIH Director’s Council of Public Representatives, and currently serves on the NIH’s Council of Councils. He also served three terms on the Advisory Committee on Blood Safety and Availability (1997-2006).He is Past Chairperson of the Board of Directors of the National Health Council (2005-2006) and is currently a board member.
He is Past Chairperson of the American Thoracic Society Public Advisory Roundtable (PAR), was the Presidential Appointee of the Board of Directors of the American Thoracic Society (2004-2005), and was Trustee on the Foundation of the American Thoracic Society (2006-2008).
Mr. Walsh is co-founder of the Plasma Users Coalition, was on the Advisory Board of the Center for Genetic Research Ethics And Law (CGREAL) at Case Western Reserve University, serves on the Executive Committee of the US COPD Coalition and is Past Chairman of the International COPD Coalition (2006-2008).
Barbara Yawn, MD (primary care) plus
Barbara P. Yawn, MD, MSc, FAAFP, is the Director of Research at Olmsted Medical Center and an adjunct professor in the Department of Family and Community Health at the University of Minnesota, both in Rochester, MN. She is a Fellow of the American Academy of Family Physicians and winner of the AAFP's 1988 and 1989 Outstanding Scientific Paper Award.
Since 1987, Dr. Yawn has published more than 180 peer-reviewed articles, in addition to producing a nationally syndicated radio health program and writing a health column for community newspapers across the country.
Dr. Yawn has served as principal investigator for several clinical trials, including: physician-directed medication for asthma care; the impact of spirometry testing in family medicine practices; and the long-term trends in herpes zoster and varicella incidence. Her work in the asthma field includes pilot studies on the national history of asthma in primary care patients; asthma school-based screening; stigmatization in children with asthma; and disease labeling in people with asthma.
Dr. Yawn received her medical degree from the University of Missouri-Columbia School of Medicine and completed her residency at the University of Minnesota at Fairview.